Sapphiros Awarded $11M from NIH RADx® Tech to Develop a Next-generation Molecular OTC Test

BOSTON, April 17, 2023 /PRNewswire/ — Sapphiros, a platform company dedicated to building the next generation of consumer diagnostic technologies, is proud to announce it has been selected by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program…